# A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement

Study · id `cardio:ct-nct07691307` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07691307](<https://clinicaltrials.gov/study/NCT07691307>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07691307

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

## Technical summary

Registry record NCT07691307. Randomized; no masking; primary purpose treatment. Start 2026-03-18 (actual); primary completion 2028-08-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT07691307, source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)
- Started: 2026-03-18 (actual) (ClinicalTrials.gov record NCT07691307, source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)
- Primary completion: 2028-08-30 (anticipated) (ClinicalTrials.gov record NCT07691307, source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)
- Completion: 2028-08-30 (anticipated) (ClinicalTrials.gov record NCT07691307, source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07691307, source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07691307-2026-07-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
- Condition: Tricuspid Valve Regurgitation
- Condition: Tricuspid Valve Insufficiency
- Condition: Tricuspid Valve Disease
- Intervention (Device): TruGamma System
- Intervention (Drug): Optimal medical therapy (OMT)
- Lead sponsor: Jiangsu Trulive Medical Co., Ltd
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Tricuspid regurgitation (`cardio:tricuspid-regurgitation`)

## Provenance

Content hash: e48de7c1ad774b0063deb9373300f68a47f968668911a8ce8fbc911ee5cc885c
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
